(19)
(11) EP 2 575 795 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
23.10.2019 Bulletin 2019/43

(45) Mention of the grant of the patent:
04.09.2019 Bulletin 2019/36

(21) Application number: 11730740.5

(22) Date of filing: 24.05.2011
(51) International Patent Classification (IPC): 
A61K 31/05(2006.01)
A61K 31/202(2006.01)
A61K 31/375(2006.01)
A61P 17/02(2006.01)
A61K 31/085(2006.01)
A61K 31/355(2006.01)
A61K 36/53(2006.01)
(86) International application number:
PCT/IB2011/001113
(87) International publication number:
WO 2011/148247 (01.12.2011 Gazette 2011/48)

(54)

STABILIZED FORMULATION COMPRISING OMEGA-3 FATTY ACIDS AND USE OF THE FATTY ACIDS FOR SKIN CARE AND/OR WOUND CARE

STABILISIERTE ZUBEREITUNG ENHALTEND OMEGA-3 FETTSÄUREN UND IHRE VERWENDUNG ZUR HAUTPFLEGE UND/ODER WUNDVERSORGUNG

COMPOSITION STABILISÉ CONTENANT D' ACIDE GRAS OMEGA-3 ET SA UTILISATION EN SOIN CUTANÉ ET/OU EN SOIN DE PLAIE


(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 26.05.2010 US 348357 P

(43) Date of publication of application:
10.04.2013 Bulletin 2013/15

(60) Divisional application:
19193607.9

(73) Proprietor: Kerecis EHF
113 Reykjavik (IS)

(72) Inventors:
  • SIGURJONSSON, Gudmundur Fertram
    IS-101 Reykjavik (IS)
  • LLIEVSKA, Biljana
    IS-400 Isafjordur (IS)
  • BALDURSSON, Baldur Tumi
    IS-105 Reykjavik (IS)

(74) Representative: Klunker IP Patentanwälte PartG mbB 
Destouchesstraße 68
80796 München
80796 München (DE)


(56) References cited: : 
EP-A1- 0 699 437
WO-A1-00/49889
GB-A- 2 458 466
US-A1- 2007 243 307
EP-A1- 1 637 130
WO-A1-2011/057183
GR-B1- 1 004 395
   
  • KARIN ENGSTRÖM ET AL: "Effect of fish oils containing different amounts of EPA, DHA, and antioxidants on plasma and brain fatty acids and brain nitric oxide synthase activity in rats", UPSALA JOURNAL OF MEDICAL SCIENCES, vol. 114, no. 4, 1 December 2009 (2009-12-01), pages 206-213, XP55005475, ISSN: 0300-9734, DOI: 10.3109/03009730903268958
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).